Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Cryptocurrency represents a revolutionary digital currency system. Understand its mechanics and implications for your financial decisions.
28,655 articlesA trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Meta has slashed about 25,000 jobs since 2022, with 700 more in Reality Labs this week. The moves spotlight a leaders...
A landmark, independent study finds racial disparities in AI-driven hiring tools used by major employers, affecting B...
Savers with a traditional 401(K) around $1.4 million can trim future tax bite by executing a Roth-conversion plan in ...
In 2026, dividend aristocrats quietly outrunning software stocks has drawn fresh money into income-focused ETFs as vo...
Micron Technology races higher on AI memory demand and supply tightness. This piece outlines why investors may consid...
The New York Fed reports 9.7% of student loan balances are 90+ days delinquent in Q1 2026, signaling rising retiremen...
Hut 8 is shifting from pure mining to an infrastructure landlord role, using long-term leases, project debt, and BTC ...
Investors bias portfolios by political leanings, potentially hurting gains. Experts say open dialogue across camps ca...
As AI tools ride into homebuilding, a new asset is emerging: institutional knowledge. Builders that centralize data a...
Analysts are arguing that Merck's sac-TMT program could unlock substantial upside for MRK, supported by a strong pipe...
Traders are loading into a high-stakes energy bet nicknamed NACHO as JPMorgan warns of June shortages. The move rippl...